EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Incidence and Prevalence of Fibrous Dysplasia/McCune-Albright Syndrome: A Nationwide Registry-Based Study in Denmark

Maartje E Meier iD, Emese Vágó, Bo Abrahamsen, Olaf M Dekkers iD, Erzsébet Horváth-Puhó, Lars Rejnmark, Natasha M Appelman-Dijkstra

The Journal of Clinical Endocrinology & Metabolism · 2024

DOI: 10.1210/clinem/dgad744 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Maartje E Meier und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands. Hauptthemen laut MEDLINE: Registries, Fibrous Dysplasia, Polyostotic. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Fibrous dysplasia/McCune-Albright syndrome (FD/MAS) is a rare genetic disorder. Incidence and prevalence are not well-studied. Epidemiological research is complicated by the rarity of FD/MAS, absence of registries, heterogeneous presentation, and possibly asymptomatic phenotype. FD/MAS may present with FGF23-mediated hypophosphatemia, of which the epidemiology is also unclear.

Objective

Evaluate incidence and prevalence of FD/MAS and FD/MAS-related hypophosphatemia.

Methods

This cohort study based on the nationwide Danish National Patient Registry from 1995-2018, included patients identified by ICD-10 codes M85.0 (monostotic FD [MFD]) and Q78.1 (polyostotic FD [PFD]/MAS). Incidence rates and prevalence were calculated and stratified by sex, age, calendar period, and diagnosis code. Cases were screened for FD-associated hypophosphatemia by diagnosis code E.83 (disorder of mineral metabolism) and dispatched vitamin D analogues.

Results

A total of 408 patients were identified, 269 with MFD (66%), 139 with PFD/MAS (34%), comparable between sexes. Incidence of FD/MAS demonstrated increasing secular trend with a rate of 3.6 per 1 000 000 person-years (95% CI: 2.9, 4.5) in 2015-2018. Incidence peaked between age 11 and 20. Prevalence of FD/MAS increased over time to 61.0 (95% CI: 54.6, 67.4) per 1 000 000 persons in 2018. The incidence rate of MFD was 1.5-fold that of PFD/MAS in the first decade, rising to 2.5-fold in the last decade. No FD/MAS cases were registered with diagnosis code or treatment for hypophosphatemia.

Conclusion

FD/MAS is rare, diagnosis peaks during adolescence without sex predominance, and MFD is most prevalent. Hypophosphatemia may be underdiagnosed and undertreated, or it may be underregistered, comparing this study to literature.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RegistriesFibrous Dysplasia, PolyostoticHumansDenmarkMaleFemalePrevalenceIncidenceAdolescentAdultChildYoung AdultMiddle AgedChild, PreschoolInfantFibroblast Growth Factor-23HypophosphatemiaAgedCohort Studies

Stichwörter der Autor:innen

epidemiologyfibrous dysplasia/McCune-Albright syndromeincidenceprevalencerare bone disorderregistry

Substanzen

Fibroblast Growth Factor-23FGF23 protein, human

Autor:innen und Institutionen

  • Department of Orthopedic Surgery, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Department of Clinical Epidemiology, Aarhus University, 8200 Aarhus N, Denmark.
  • OPEN Patient Data Explorative Network, University of Southern Denmark, 5000 Odense C, Denmark.
  • Department of Medicine, Holbaek Hospital, 4300 Holbaek, Denmark.
  • Department of Clinical Epidemiology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Department of Internal Medicine, Division of Endocrinology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.

ORCID-Profile: Maartje E Meier, Olaf M Dekkers

Zitieren

APA

Meier, M. E., Vágó, E., Abrahamsen, B., Dekkers, O. M., Horváth-Puhó, E., Rejnmark, L., & Appelman-Dijkstra, N. M. (2024). Incidence and Prevalence of Fibrous Dysplasia/McCune-Albright Syndrome: A Nationwide Registry-Based Study in Denmark. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad744

Vancouver

Meier ME, Vágó E, Abrahamsen B, Dekkers OM, Horváth-Puhó E, Rejnmark L, et al. Incidence and Prevalence of Fibrous Dysplasia/McCune-Albright Syndrome: A Nationwide Registry-Based Study in Denmark. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgad744

BibTeX
@article{Meier2024,
  author = {Meier, Maartje E and Vágó, Emese and Abrahamsen, Bo and Dekkers, Olaf M and Horváth-Puhó, Erzsébet and Rejnmark, Lars and Appelman-Dijkstra, Natasha M},
  title = {Incidence and Prevalence of Fibrous Dysplasia/McCune-Albright Syndrome: A Nationwide Registry-Based Study in Denmark},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2024},
  doi = {10.1210/clinem/dgad744}
}
Kostenlos starten →